David Boles advises clients on capital markets and securities regulation matters. He represents issuers, investment banks and investors on initial public offerings, private placements and other equity capital markets transactions across the Europe, Middle East and Africa region, including US-registered offerings by foreign private issuers. In the past three years, David has advised on more than 30 equity capital markets transactions.

Download full bio 


  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

  • Exscientia – $510.4 Million IPO 

  • SimilarWeb – $176 Million IPO 

  • Pharming Group – Direct Listing 

  • Nanobiotix – $113 Million IPO 

  • View all


  • Duke University School of Law
    JD, magna cum laude, 2002

  • Rice University
    BA, 1995

Admissions & Credentials

New York

England & Wales